DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Rini BI, Wilding G, Hudes G et al.
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
J Clin Oncol 2009;
27: 4462-4468
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.